Drug recall · January 17, 2024
Desloratadine Tablets USP 5mg a) recall
Why: CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202.
- Lots / codes
Lot # G201822, exp. date Jan 2024, 100 count G201823, exp. date Jan 2024, 100 count G201824, exp. date Jan 2024, 500 count
- Quantity
- 100=29,184 bottles; 500=2922 bottles
- Company
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Distribution
- Product was distributed nationwide.
- Initiated
- December 20, 2023 · Voluntary: Firm initiated
- Classified
- January 9, 2024
- Reported
- January 17, 2024
- Ended
- April 4, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Desloratadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.